Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Regis Healthcare Ltd. ( (AU:REG) ) has provided an announcement.
Regis Healthcare Limited has notified the market that 60,164 performance rights (ASX code REGAA) have lapsed after the conditions attached to those rights were not met or became incapable of being satisfied, with cessation dated 6 November 2025. The lapse reduces the pool of potential future equity issuance under this particular incentive instrument, marginally tightening the company’s prospective share capital structure and indicating that performance or vesting hurdles linked to these rights were not achieved.
The most recent analyst rating on (AU:REG) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Regis Healthcare Ltd. stock, see the AU:REG Stock Forecast page.
More about Regis Healthcare Ltd.
Regis Healthcare Limited is an Australian-listed company in the aged care and health services sector, operating residential aged care facilities and related care services for older Australians. It focuses on providing long-term care, clinical support, and accommodation options, operating under ASX ticker REG.
Average Trading Volume: 857,351
Technical Sentiment Signal: Buy
Current Market Cap: A$2.08B
See more data about REG stock on TipRanks’ Stock Analysis page.